The researchers discovered that upregulation of miR-141 led to a downregulation of HOXC6 and subsequent inhibition of the TGF-β signaling pathway, which effectively repressed EMT and reduced the viability, migration, and invasion abilities of laryngeal cancer cells, as well as tumor growth in vivo. The gene discussed is TGFB1; the disease is neoplasm.